Medtronic Plc
Research Medtronic Plc (MDT) on Bullrun: valuation model: 5.4% undervalued, market cap USD 116.68B, P/E 24.5, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMDT
- ExchangeNYSE
- CountryIreland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal5.4% undervalued
- Market capUSD 116.68B
- P/E24.5
- Dividend yield1.6%
- Financial periodQ2 2026
- RevenueUSD 9.81B
- Net incomeUSD 1.24B
- Free cash flowUSD 2.09B
- Gross margin65.4%
Valuation Snapshot
Bullrun's latest valuation model marks Medtronic Plc as 5.4% undervalued; latest market cap is USD 116.68B; P/E is 24.5; dividend yield is 1.6%.
Peer valuation comparison
Latest P/E is 24.46x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 1.59% versus a Healthcare sector median of 2.11% (24.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 33.54B | USD 4.66B | USD 5.19B | 65.3% | 3.61 | USD 2.22B | USD 2.87B | USD 48.02B |
| FY2024 | USD 32.36B | USD 3.68B | USD 5.20B | 65.3% | 2.76 | USD 1.28B | USD 1.09B | USD 50.21B |
| FY2023 | USD 31.23B | USD 3.76B | USD 4.58B | 65.7% | 2.82 | USD 1.54B | USD 20.00M | USD 51.48B |
| FY2022 | USD 31.69B | USD 5.04B | USD 5.98B | 68.0% | 3.73 | USD 3.71B | USD 3.74B | USD 52.55B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 116.68B | 24.5 | 1.6% | 1.43 |
| 2025 | 2025-12-31 | USD 123.15B | 26.0 | 0.7% | 0.7 |
| 2024 | 2024-12-31 | USD 102.43B | 24.4 | 3.5% | 2.79 |
| 2023 | 2023-12-29 | USD 109.54B | 26.7 | 3.3% | 2.75 |
| 2022 | 2022-12-30 | USD 103.38B | 24.1 | 3.4% | 2.67 |
| 2021 | 2021-12-31 | USD 139.09B | 29.8 | 2.4% | 2.47 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.43 USD, yield 1.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.8 USD |
| FY2024 | 2.76 USD |
| FY2023 | 2.72 USD |
| FY2022 | 2.52 USD |
About Medtronic Plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Medtronic Plc overvalued or undervalued?
Bullrun's valuation model currently marks Medtronic Plc as 5.4% undervalued.
What is Medtronic Plc's market cap?
Medtronic Plc's market capitalization is USD 116.68B.
What is Medtronic Plc's P/E ratio?
Medtronic Plc's price-to-earnings (P/E) ratio is 24.5.
Does Medtronic Plc pay a dividend?
Medtronic Plc has a dividend yield of 1.6%.
What does Medtronic Plc do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.